Orthopediatrics (KIDS) Cash & Equivalents Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 156.03% |
| 10 | Orthopediatrics | 394.83 Mn | 346.02 Mn | 43.39 Mn | -63.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -63.54% |
| Dec 31, 2025 | -55.37% |
| Sep 30, 2025 | -67.04% |
| Jun 30, 2025 | 54.02% |
| Mar 31, 2025 | 54.80% |
| Dec 31, 2024 | 41.10% |
| Sep 30, 2024 | 379.77% |
| Jun 30, 2024 | 197.82% |
| Mar 31, 2024 | -37.67% |
| Dec 31, 2023 | 245.40% |
| Jun 30, 2023 | -73.89% |
| Mar 31, 2023 | 92.99% |
| Dec 31, 2022 | 17.67% |
| Jun 30, 2022 | 252.09% |
| Mar 31, 2022 | -16.19% |
| Dec 31, 2021 | -73.43% |
| Sep 30, 2021 | -92.83% |
| Jun 30, 2021 | -90.65% |
| Mar 31, 2021 | -60.01% |
| Dec 31, 2020 | -59.37% |
| Sep 30, 2020 | 349.30% |
| Jun 30, 2020 | 417.22% |
| Mar 31, 2020 | 1.53% |
| Dec 31, 2019 | 16.62% |
| Sep 30, 2019 | -19.60% |
| Jun 30, 2019 | -17.54% |
| Mar 31, 2019 | 52.57% |
| Dec 31, 2018 | 42.53% |
| Sep 30, 2018 | 993.07% |
| Jun 30, 2018 | 1,049.44% |
| Mar 31, 2018 | 1,314.19% |
| Dec 31, 2017 | 2,546.49% |
| Sep 30, 2017 | 70.19% |
| Dec 31, 2016 | -58.51% |